<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01968408</url>
  </required_header>
  <id_info>
    <org_study_id>KB/125/2012</org_study_id>
    <nct_id>NCT01968408</nct_id>
  </id_info>
  <brief_title>Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children</brief_title>
  <official_title>Effectiveness of Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children: a Randomized, Double-blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      AIM: To determine the efficacy of Lactobacillus reuteri DSM 17938 at a dose of 10(9) CFU for
      the prevention of nosocomial diarrhea.

      TRIAL DESIGN: Double-blind, placebo controlled RCT. INTERVENTION: L reuteri DSM 17938 in a
      daily dose of 10(9) CFU. PRIMARY OUTCOME: Nosocomial diarrhoea (3 or more loose or watery
      stools in a 24 h that will occur more than 72 h after admission).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nosocomial diarrhea is a common problem in hospitalized children. Previously, it has been
      documented that the administration of L reuteri DSM 17938 at a dose of 10(8) colony forming
      units (CFU) compared with placebo had no effect on the overall incidence of nosocomial
      diarrhea (Wanke &amp; Szajewska, J Pediatr 2012). Whether higher doses of L reuteri DSM 17938
      have such effects needs to be substantiated in further randomized trials.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of nosocomial diarrhea (defined as the passage of 3 or more loose or watery stools in a 24-hour period that will occur more than 72 hours after admission)</measure>
    <time_frame>Any time starting 72 h after admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of diarrhea- passage of 3 or more loose or watery stools in a 24-h period</measure>
    <time_frame>from the time of admission to the time of discharge of the hospital-expected average 3-5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of diarrhea (ie, time till the last loose or watery stool from the onset of diarrhea)</measure>
    <time_frame>during hospitalisation (expected average 3-5 days) and 72 h after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need and the length of intravenous rehydration due to diarrhea</measure>
    <time_frame>During the hospitalization-expected average 3-5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolongation of the hospitalization due to nosocomial diarrhea</measure>
    <time_frame>during the hospitalization-expected average 3-5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of rotavirus diarrhea (ie, detection of rotavirus or antigen in the stools)</measure>
    <time_frame>72 hours after admission to the hospital to 72 hours after discharge</time_frame>
    <description>Positive test for rotavirus or antigen in the stool sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of chronic diarrhea- lasting more than 14 days</measure>
    <time_frame>untill 14 days after onset of diarrhea</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>During hospitalisation-expected average 3-5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>During hospitalisation (expected average 3-5 days) plus 72 h after discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Diarrhea</condition>
  <arm_group>
    <arm_group_label>L. reuteri DSM 17938</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus reuteri DSM 17938,10(9)CFU/daily (for the duration of hospitalization)
ARM I: Rotavirus vaccinated patients
ARM II: Non-rotavirus vaccinated patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo consists of an identical formulation in all respects except that the live probiotic bacteria were excluded
for the duration of hospitalization</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus reuteri DSM 17938</intervention_name>
    <description>10(9) CFU/daily</description>
    <arm_group_label>L. reuteri DSM 17938</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 1-48 mo admitted to the hospital for reasons other than diarrhea

          -  Signed informed consent.

        Exclusion Criteria:

          -  Acute gastroenteritis within 3 days before admission

          -  Symptoms other than diarrhea suggesting gastroenteritis

          -  Use of probiotics within 7 days before admission

          -  Immunodeficiency disorders

          -  Breastfeeding &gt;50%

          -  Underlying gastrointestinal tract disorder

          -  Malnutrition (weight/high &lt;3pc)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>48 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanna Szajewska, MD, Profesor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pediatrics, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>01-410</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2012</study_first_submitted>
  <study_first_submitted_qc>October 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2013</study_first_posted>
  <last_update_submitted>June 17, 2015</last_update_submitted>
  <last_update_submitted_qc>June 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Hanna Szajewska</investigator_full_name>
    <investigator_title>Proffesor</investigator_title>
  </responsible_party>
  <keyword>nosocomial diarrhea</keyword>
  <keyword>Lactobacillus reuteri DSM 17938</keyword>
  <keyword>rotavirus diarrhea</keyword>
  <keyword>probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

